I don't see how GE making an offer to buy Biocurex would be in our long-term interests. I am still hoping for strong, dramatic increases in the share price commensurate with the risks we have assumed investing in a tiny biotech. A buyout shortly after the GE/Abbott deal closes would limit our return. I want to be holding shares in an independent pure RECAF play over the long term, when we are on the front pages of the major newpapers. I don't want to be picked off before the story even gets told!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.